Institutional Cluster

ABT

ABBOTT LABORATORIES
MIXED
Impact 4/10
Horizonweeks Processed2mo ago
Institutional cluster: 4 buyers, 5 sellers (mixed)
Actionable Insight ◆ Mixed

The 3:1 ratio of selling to buying dollar volume suggests institutional rotation out of ABT despite a solid earnings beat and raised guidance. Monitor upcoming Q3 2026 results for any guidance revision or growth deceleration that could validate the selling. The insider buy of $174K is too small to counter the institutional signal — treat this as a cautionary read on near-term momentum.

DirectionMixed
Confidencemedium
Horizonweeks
Latest settled — T+20d ⚠ clustered
ABT ▲ +6.40% at T+20d
NEUTRAL call ✓ call won +6.40% · α vs SPY +3.42% · entry $105.70 → $112.47
Next anchor: T+60d in 24d
Latest observation: T+41 -9.75% FF3 residual α
Entry anchored
Jul 30, 03:59 PM ET
via exchange tick
T+1d
+1.35%
call +1.35% · α -0.06%
$107.13
settled 2mo ago
T+5d
+2.00%
call +2.00% · α -1.51%
$107.81
settled 8w ago
T+20d
+6.40%
call +6.40% · α +3.42%
$112.47
settled 5w ago
T+60d
—
call — · α —
—
in 24d

Executive Summary

A mixed institutional cluster in ABT for Q2 2026 shows four asset managers adding $103.5M in net new holdings (led by Davenport & Co. and Mirae Asset) while five managers trimmed $296.3M, dominated by Assenagon's $162.7M reduction. The cluster follows Abbott's Q2 earnings beat (adj. EPS $1.31 vs. $1.28 consensus) and raised FY2026 guidance, but the selling volume is nearly 3x the buying, suggesting profit-taking or rotation despite the positive earnings catalyst. Insider buying of $174K provides mild corroboration but does not offset the institutional selling weight.

Key Financial Metrics

Direction
distributing
Buy Value
$360.5M
Sell Value
$407.1M
Net Flow
-$192.8M

Institutional Positions

Net institutional flow: -$192.8M

▲ Buyers (4)

InstitutionActionChangePosition ValueValue Δ
Davenport & CoADD+92.3%$166.7M$69.4M
Mirae Asset Global Investments Co.ADD+38%$172.0M$31.0M
Exchange Traded ConceptsADD+31.7%$6.9M$967.0K
Banque Pictet & CieADD+32.4%$14.9M$2.2M

▼ Sellers (5)

InstitutionActionChangePrev ValueValue Δ
Assenagon Asset ManagementTRIM-27.3%$454.8M-$162.7M
Qrg Capital ManagementTRIM-28.7%$29.8M-$11.0M
Robeco Institutional Asset Management B.v.TRIM-56.2%$16.8M-$10.3M
Benjamin EdwardsTRIM-35.6%$36.8M-$15.9M
Pictet Asset Management HoldingTRIM-52.9%$165.2M-$96.4M

Key Facts

  • 4 institutional buyers added $103.5M in ABT positions during Q2 2026
  • 5 institutional sellers trimmed $296.3M, with Assenagon alone cutting $162.7M
  • Net institutional outflow of ~$192.8M in Q2 2026
  • Cluster follows Q2 2026 earnings beat (adj. EPS $1.31 vs. $1.28 consensus) and raised FY guidance
  • All participants are asset managers — no activist or hedge fund names in the cluster
  • One insider open-market buyer added $174K, providing mild conviction signal

Financial Impact

4 institutional buyers added $103.5M in new ABT holdings while 5 sellers trimmed $296.3M, resulting in a net institutional outflow of approximately $192.8M during Q2 2026

institutional ownershipnet dollar flow

Risk Factors

  • 13F data has a 45-day reporting lag — positions may have been reversed since quarter-end
  • All participants are asset managers, not activists; selling may reflect portfolio rebalancing rather than a fundamental thesis break
  • The cluster is dominated by one large seller (Assenagon, $162.7M trim) which could be a single-fund strategic shift
  • Historical win rate on ABT reports is only 29% at T+20, suggesting limited predictive power

Market Snapshot

Price
$105.59
Volume
100
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
71% bullish (35 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-ABT-2026-Q2
22 reports for ABT
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+20▲ +17.16%Jul 1, 2026
Filters
Rows
Reports for ABT — sortable, filterable
TypeNow
Oct 2, 2026
today
ANALYST-UPGRADE
BULLISH ★ 4/10
$98.00 awaiting T+5awaiting T+5——
Sep 14, 2026
18d ago
Court Ruling
NEUTRAL ★ 1/10
$103.09 $102.98▼ −0.11%▼ −1.77%—
Aug 11, 2026
7w ago
Court Ruling
NEUTRAL ★ 2/10
$109.72 $112.68▲ +2.70%▲ +3.10%—
Aug 11, 2026
7w ago
Court Ruling
NEUTRAL ★ 1/10
$109.72 $112.68▲ +2.70%▲ +3.10%—
Jul 31, 2026
9w ago
Institutional Cluster
MIXED ★ 4/10
$105.70 $107.81▲ +2.00%▼ −1.51%—
Jul 31, 2026
9w ago
Court Ruling
NEUTRAL ★ 2/10
$105.70 $107.81▲ +2.00%▼ −1.51%—
Jul 24, 2026
10w ago
Court Ruling
BULLISH ★ 5/10
$103.06 $105.61▲ +2.47%▲ +2.10%—
Jul 16, 2026
11w ago
8-K
BULLISH ★ 6/10
$98.83 $100.75▲ +1.94%▲ +3.61%—
Jul 14, 2026
11w ago
Court Ruling
NEUTRAL ★ 3/10
$88.96 $101.66▲ +14.28%▲ +15.57%—
Jul 7, 2026
12w ago
Court Ruling
NEUTRAL ★ 1/10
$95.84 $88.96▼ −7.18%▼ −7.73%—
Showing 10 of 22

US Market Status

Market Open — Closes in 6h 24m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 31, 2026